Come up with a name for your new list and we'll add to it:
bioAffinity Technologies raised a round of funding on March 09, 2017. Investors include
San Antonio Economic Development Corporation.
bioAffinity Technologies is developing a diagnostic agent that aims to literally highlight cancer cells in patients sputum-basically phlegm that's coughed up from the lungs. When a synthetic molecule …